Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00759187 · ClinicalTrials.gov registry record · Phase 3

Evaluate Clinical Research From Commerical Oral Care Products

A Phase 3 study, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 3
Development phase
25
Enrollment target

NCT00759187 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00759187, a Phase 3 study, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 3
Development phase
25 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a clinical study comparing anti-plaque efficacy of commercial oral care products.

Interventions

  • DRUG Chlorhexidine Gluconate
  • DRUG Fluoride
  • DRUG Triclosan/Fluoride

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2008-01
Est. Completion 2008-04
Phase Phase 3

Sponsor

Colgate Palmolive

51 total trials

What the Registry Record Tells You About NCT00759187

The ClinicalTrials.gov registry entry for NCT00759187 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Chlorhexidine Gluconate is the first listed.

NCT00759187 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00759187 about?

NCT00759187 is a clinical study titled "Evaluate Clinical Research From Commerical Oral Care Products". The purpose of this study is to conduct a clinical study comparing anti-plaque efficacy of commercial oral care products.

What is the current status of trial NCT00759187?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2008-01. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00759187?

The interventions under investigation include: Chlorhexidine Gluconate (DRUG), Fluoride (DRUG), Triclosan/Fluoride (DRUG).

Who is sponsoring clinical trial NCT00759187?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.